NYSE:RFL Rafael (RFL) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free RFL Stock Alerts $1.76 +0.05 (+2.92%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$1.71▼$1.7850-Day Range$1.66▼$1.9252-Week Range$1.44▼$2.52Volume26,022 shsAverage Volume25,420 shsMarket Capitalization$43.26 millionP/E Ratio17.60Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Rafael alerts: Email Address Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. About Rafael Stock (NYSE:RFL)Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More RFL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RFL Stock News HeadlinesApril 19, 2024 | msn.comRafael Devers (knee) out of Red Sox lineup again but club has ruled out ILApril 19, 2024 | msn.com‘Built for sustainable success’: Rafael Stone reacts to new contract with RocketsApril 19, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 19, 2024 | msn.comRed Sox lineups: Rafael Devers sits out Pirates series opener, but won’t go on injured listApril 18, 2024 | msn.comRed Sox third baseman Rafael Devers has a bone bruise in his sore left kneeApril 18, 2024 | msn.comRed Sox’ Rafael Devers ‘not going to rush’ back from bone bruiseApril 18, 2024 | msn.comSeeking ‘peace of mind,’ Rafael Devers to undergo MRI on ailing left kneeApril 18, 2024 | msn.comRed Sox lineups: Rafael Devers, Masataka Yoshida both sitApril 19, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 18, 2024 | msn.comRed Sox Receive Disappointing Rafael Devers Injury UpdateApril 18, 2024 | msn.comInjuries incoming: Red Sox’ Rafael Devers to undergo MRI, Tyler O’Neill to ILApril 18, 2024 | msn.comRed Sox manager has positive news on Rafael Devers’ injuryApril 18, 2024 | cbsnews.comSan Rafael suspect who shot into victims car during dispute arrestedApril 17, 2024 | msn.comRafael Nadal vs. Alex de Minaur - Ongoing rivalryApril 17, 2024 | forbes.comRafael Nadal Loses To Alex De Minaur in Barcelona, Upcoming Schedule In FluxApril 17, 2024 | msn.comShaky Rafael Nadal ends his Barcelona Open campaignApril 17, 2024 | msn.comVideo: Rafael Stone, Ime Udoka reflect on breakthrough season for RocketsApril 17, 2024 | msn.comInjury departures of Garrett Whitlock, Rafael Devers compound Red Sox loss to GuardiansApril 17, 2024 | msn.com‘Frustrated’ Red Sox’ Rafael Devers feels knee pain, likely to get imagingApril 17, 2024 | msn.comRed Sox’ Rafael Devers leaves game with knee discomfort, might need imagingApril 17, 2024 | msn.comRafael Nadal wins in straight sets in tennis comeback at Barcelona OpenApril 16, 2024 | msn.comTyler O’Neill avoids a concussion, but needs a few days after scary Fenway collision with Rafael DeversApril 16, 2024 | forbes.comRockets Extend Contract Of General Manager Rafael StoneApril 16, 2024 | msn.comRafael Devers leaves Red Sox game TuesdayApril 16, 2024 | msn.comRafael Nadal makes winning return at Barcelona Open and says he has ‘no pain’April 16, 2024 | msn.comRafael Nadal wins first clay court match in 681 days, defeating Flavio Cobolli in BarcelonaApril 16, 2024 | msn.comRafael Nadal is on the court for the last Barcelona Open of his careerSee More Headlines Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/19/2024Next Earnings (Estimated)6/11/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Real estate Sub-IndustryN/A Current SymbolNYSE:RFL CUSIPN/A CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.10 Trailing P/E Ratio17.60 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,880,000.00 Net Margins776.36% Pretax Margin827.64% Return on Equity-4.31% Return on Assets-4.22% Debt Debt-to-Equity RatioN/A Current Ratio23.01 Quick Ratio23.01 Sales & Book Value Annual Sales$280,000.00 Price / Sales154.50 Cash FlowN/A Price / Cash FlowN/A Book Value$3.98 per share Price / Book0.44Miscellaneous Outstanding Shares24,580,000Free Float22,199,000Market Cap$43.26 million OptionableOptionable Beta1.32 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Howard S. Jonas (Age 68)Founder & Executive Chairman Comp: $40kMr. William Conkling (Age 52)CEO & President Comp: $751.95kMr. David A. Polinsky Esq. (Age 52)Chief Financial Officer Comp: $363.3kMs. Barbara A. Ryan (Age 64)Investor Relations Officer Mr. Gus KodershaChief Technical Operations OfficerDr. Rick EwingHead of Drug DiscoveryDr. John Mayer Goldberg M.D. (Age 51)Chief Medical Officer Ms. Joyce J. Mason Esq. (Age 65)Corporate Secretary More ExecutivesKey CompetitorsAadi BioscienceNASDAQ:AADIEUDA HealthNASDAQ:EUDABolt BiotherapeuticsNASDAQ:BOLTRockwell MedicalNASDAQ:RMTIXilio TherapeuticsNASDAQ:XLOView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 11,419 shares on 3/11/2024Ownership: 2.345%Vanguard Group Inc.Bought 11,419 shares on 2/15/2024Ownership: 2.345%Northern Trust CorpSold 9,024 shares on 2/13/2024Ownership: 0.110%Acuitas Investments LLCBought 88,940 shares on 2/2/2024Ownership: 1.315%Simplex Trading LLCBought 2,500 shares on 2/2/2024Ownership: 0.000%View All Institutional Transactions RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed in 2024? Rafael's stock was trading at $1.83 at the start of the year. Since then, RFL stock has decreased by 3.8% and is now trading at $1.76. View the best growth stocks for 2024 here. Are investors shorting Rafael? Rafael saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 38,800 shares, a drop of 36.0% from the March 15th total of 60,600 shares. Based on an average daily volume of 26,500 shares, the short-interest ratio is presently 1.5 days. View Rafael's Short Interest. When is Rafael's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 11th 2024. View our RFL earnings forecast. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) posted its earnings results on Wednesday, March, 13th. The company reported ($0.08) EPS for the quarter. The firm earned $0.07 million during the quarter. Rafael had a negative trailing twelve-month return on equity of 4.31% and a net margin of 776.36%. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:RFL) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.